Literature DB >> 14982596

Pathogenesis of pleural infection.

Chadi A Hage1, Kamal abdul-Mohammed, Veena B Antony.   

Abstract

The pleura responds to the presence of infecting organisms with a vigorous inflammatory response associated with an exudation of white blood cells and proteins. The development and outcome of pleural infections is a function of a balance between the virulence of the invading microorganism and the immune reaction involving professional immune cells as well as the pleural mesothelial cells. Most commonly, pleural infection occurs after invasion through the lung parenchyma and a breach in the viscera pleura resulting in the formation of a parapneumonic process. Upon infection, the microorganisms are recognized by the pleural mesothelial cell, which remains the first line of defence. Pleural responses to infection include those of innate immunity as well as adaptive or acquired immunity. Innate and acquired immune responses are closely linked. In this review, we discuss the different virulence factors that allow microorganisms to infect the pleura and the role of the pleural mesothelial cells in bridging the innate and acquired immune responses.

Entities:  

Mesh:

Year:  2004        PMID: 14982596     DOI: 10.1111/j.1440-1843.2003.00539.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

1.  Mechanisms of T-lymphocyte accumulation during experimental pleural infection induced by Mycobacterium bovis BCG.

Authors:  Mariana C Souza; Carmen Penido; Maria F S Costa; Maria Graças Henriques
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

2.  Effects of downregulation of aquaporin1 by peptidoglycan and lipopolysaccharide via MAPK pathways in MeT-5A cells.

Authors:  Lihua Liu; Canmao Xie
Journal:  Lung       Date:  2011-06-04       Impact factor: 2.584

3.  Differential Pneumococcal Growth Features in Severe Invasive Disease Manifestations.

Authors:  Marien I de Jonge; Amelieke J H Cremers; Daan W Arends; Wynand Alkema; Indri Hapsari Putri; Christa E van der Gaast-de Jongh; Marc Eleveld; Jeroen D Langereis; Quirijn de Mast; Jacques F Meis
Journal:  Microbiol Spectr       Date:  2022-06-09

Review 4.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

5.  Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis.

Authors:  Milena Marques P Acencio; Francisco S Vargas; Evaldo Marchi; Gabriela G Carnevale; Lisete R Teixeira; Leila Antonangelo; V Courtney Broaddus
Journal:  Lung       Date:  2007-10-12       Impact factor: 2.584

6.  Immune targeting of the pleural space by intercostal approach.

Authors:  Georg F Weber
Journal:  BMC Pulm Med       Date:  2015-02-18       Impact factor: 3.317

Review 7.  Mycoplasma pneumoniae Pleural Effusion in Adults.

Authors:  Chang Ho Kim; Jaehee Lee
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

8.  HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis.

Authors:  Wei-Lin Chen; Mei-Chuan Chen; Shang-Fu Hsu; Shih-Hsin Hsiao; Chi-Li Chung
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.